Health Condition 1: O280- Abnormal hematological finding onantenatal screening of mother
Conditions
Interventions
Intervention1: FERRIC CARBOXYMALTOSE: Dose: 1000mg
Route: Intravenous
Frequency: once or twice ( based on requirement)
Duration of intervention:After 4 weeks of administration
Intervention2: nil: nil
Sponsors
Dr Loshini S
Eligibility
Inclusion criteria
Inclusion criteria: 1.All pregnant women of 16-34 weeks of gestation who had been diagnosed with iron deficiency anaemia 2.All pregnant of 16-34 weeks of gestation who are noncompliant to oral iron therapy
Exclusion criteria
Exclusion criteria: 1.Other causes anemia such as megaloblastic anemia ,sickle cell anemia, thalassemia. 2.Exclusions were chronic diseases including hepatitis and HIV, elevated serum creatinine levels, History of anaphylactic reaction to intravenous iron infusion, hemochromatosis, or other iron store sickness, significant cardiovascular disease
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| to determine cost effectiveness, safety & acceptability of FCM & iron sucroseTimepoint: At the time of drug administration | — |
Primary
| Measure | Time frame |
|---|---|
| Comparing the improvement in hemoglobin levels following administration of iron sucrose and FCMTimepoint: baseline hemoglobin will be measured. 4weeks and 8 weeks following drug administration will be checked | — |
Countries
India
Contacts
Public ContactDr Loshini s
Dr. M.G.R educational and research institute university
Outcome results
None listed